Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Status: Enrolling
Updated:  12/31/1969
Hapworth Psychiatric Medical PLLC
mi
from
New York, NY
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Status: Enrolling
Updated: 12/31/1969
Hapworth Psychiatric Medical PLLC
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Status: Enrolling
Updated:  12/31/1969
Carolina Partners c/o Tripha Life Sciences
mi
from
Raleigh, NC
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Status: Enrolling
Updated: 12/31/1969
Carolina Partners c/o Tripha Life Sciences
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Status: Enrolling
Updated:  12/31/1969
Intend Research
mi
from
Norman, OK
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Status: Enrolling
Updated: 12/31/1969
Intend Research
mi
from
Norman, OK
Click here to add this to my saved trials
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Status: Enrolling
Updated:  12/31/1969
IPS Research Company
mi
from
Oklahoma City, OK
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Status: Enrolling
Updated: 12/31/1969
IPS Research Company
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Status: Enrolling
Updated:  12/31/1969
Texas Center for Drug Development, P.A.
mi
from
Houston, TX
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Status: Enrolling
Updated: 12/31/1969
Texas Center for Drug Development, P.A.
mi
from
Houston, TX
Click here to add this to my saved trials
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Status: Enrolling
Updated:  12/31/1969
Ericksen Research And Development
mi
from
Clinton, UT
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Status: Enrolling
Updated: 12/31/1969
Ericksen Research And Development
mi
from
Clinton, UT
Click here to add this to my saved trials
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Status: Enrolling
Updated:  12/31/1969
Hawkins Psychiatry, PC
mi
from
Arlington, TX
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Status: Enrolling
Updated: 12/31/1969
Hawkins Psychiatry, PC
mi
from
Arlington, TX
Click here to add this to my saved trials
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Status: Enrolling
Updated:  12/31/1969
Excell Research, Inc.
mi
from
Oceanside, CA
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Status: Enrolling
Updated: 12/31/1969
Excell Research, Inc.
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Status: Enrolling
Updated:  12/31/1969
RxClinicals
mi
from
Crystal Lake, IL
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Status: Enrolling
Updated: 12/31/1969
RxClinicals
mi
from
Crystal Lake, IL
Click here to add this to my saved trials
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Status: Enrolling
Updated:  12/31/1969
Arocha Research Center Inc
mi
from
Miami, FL
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
A 6-Month, Multicenter, Double-Blind, Randomized, Flexible-Dose, Parallel-Group Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Status: Enrolling
Updated: 12/31/1969
Arocha Research Center Inc
mi
from
Miami, FL
Click here to add this to my saved trials
Burst Suppression Anesthesia for Treatment of Severe Depression
Burst Suppression Anesthesia for Treatment of Severe Depression
Status: Enrolling
Updated:  12/31/1969
University Neuropsychiatric Institute
mi
from
Salt Lake City, UT
Burst Suppression Anesthesia for Treatment of Severe Depression
Burst Suppression Anesthesia for Treatment of Severe Depression
Status: Enrolling
Updated: 12/31/1969
University Neuropsychiatric Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Neurobiological Effects of Light on MDD
Neurobiological Effects of Light on MDD
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Neurobiological Effects of Light on MDD
Neurobiological Effects of Light on MDD
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Depressed Mood Improvement Through Nicotine Dosing (Depressed MIND Study)
Depressed Mood Improvement Through Nicotine Dosing (Depressed MIND Study)
Status: Enrolling
Updated:  12/31/1969
Vanderbilt Psychiatric Hospital
mi
from
Nashville, TN
Depressed Mood Improvement Through Nicotine Dosing (Depressed MIND Study)
Depressed Mood Improvement Through Nicotine Dosing (Depressed MIND Study)
Status: Enrolling
Updated: 12/31/1969
Vanderbilt Psychiatric Hospital
mi
from
Nashville, TN
Click here to add this to my saved trials
Software Treatments for Actively Reducing Severity of Cognitive Deficits in MDD (STARS-MDD)
A Randomized, Double-blind, Controlled, 6-week Trial to Assess the Impact of Novel Digital Interventions Designed to Improve Cognitive Dysfunction as Adjunct Therapy to Antidepressant Medication in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
CNS Network
mi
from
Garden Grove, CA
Software Treatments for Actively Reducing Severity of Cognitive Deficits in MDD (STARS-MDD)
A Randomized, Double-blind, Controlled, 6-week Trial to Assess the Impact of Novel Digital Interventions Designed to Improve Cognitive Dysfunction as Adjunct Therapy to Antidepressant Medication in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
CNS Network
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Software Treatments for Actively Reducing Severity of Cognitive Deficits in MDD (STARS-MDD)
A Randomized, Double-blind, Controlled, 6-week Trial to Assess the Impact of Novel Digital Interventions Designed to Improve Cognitive Dysfunction as Adjunct Therapy to Antidepressant Medication in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Behavioral Clinical Research, Inc.
mi
from
North Miami, FL
Software Treatments for Actively Reducing Severity of Cognitive Deficits in MDD (STARS-MDD)
A Randomized, Double-blind, Controlled, 6-week Trial to Assess the Impact of Novel Digital Interventions Designed to Improve Cognitive Dysfunction as Adjunct Therapy to Antidepressant Medication in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Behavioral Clinical Research, Inc.
mi
from
North Miami, FL
Click here to add this to my saved trials
Software Treatments for Actively Reducing Severity of Cognitive Deficits in MDD (STARS-MDD)
A Randomized, Double-blind, Controlled, 6-week Trial to Assess the Impact of Novel Digital Interventions Designed to Improve Cognitive Dysfunction as Adjunct Therapy to Antidepressant Medication in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Innovative Clinical Research, Inc.
mi
from
North Miami, FL
Software Treatments for Actively Reducing Severity of Cognitive Deficits in MDD (STARS-MDD)
A Randomized, Double-blind, Controlled, 6-week Trial to Assess the Impact of Novel Digital Interventions Designed to Improve Cognitive Dysfunction as Adjunct Therapy to Antidepressant Medication in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Innovative Clinical Research, Inc.
mi
from
North Miami, FL
Click here to add this to my saved trials
Software Treatments for Actively Reducing Severity of Cognitive Deficits in MDD (STARS-MDD)
A Randomized, Double-blind, Controlled, 6-week Trial to Assess the Impact of Novel Digital Interventions Designed to Improve Cognitive Dysfunction as Adjunct Therapy to Antidepressant Medication in Adults With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Segal Trials
mi
from
Charleston, NC
Software Treatments for Actively Reducing Severity of Cognitive Deficits in MDD (STARS-MDD)
A Randomized, Double-blind, Controlled, 6-week Trial to Assess the Impact of Novel Digital Interventions Designed to Improve Cognitive Dysfunction as Adjunct Therapy to Antidepressant Medication in Adults With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Segal Trials
mi
from
Charleston, NC
Click here to add this to my saved trials
Cognitive Behavioral Group Therapy for the Management of Menopause Symptoms in Mood Disorders
Cross-Cultural Cognitive Behavioral Group Therapy: Evaluating the Effectiveness of a Manualized Cognitive Behavior Group Therapy Treatment for the Management of Menopause Symptoms in a Mood and Anxiety Disorder Population
Status: Enrolling
Updated:  12/31/1969
University Hospitals Cleveland Medical Center - Mood Disorders Program
mi
from
Cleveland, OH
Cognitive Behavioral Group Therapy for the Management of Menopause Symptoms in Mood Disorders
Cross-Cultural Cognitive Behavioral Group Therapy: Evaluating the Effectiveness of a Manualized Cognitive Behavior Group Therapy Treatment for the Management of Menopause Symptoms in a Mood and Anxiety Disorder Population
Status: Enrolling
Updated: 12/31/1969
University Hospitals Cleveland Medical Center - Mood Disorders Program
mi
from
Cleveland, OH
Click here to add this to my saved trials
Open Label Ketamine Treatment for Major Depressive Disorder in Veterans
An Open Label Study of the Effects of Ketamine on a Veteran Clinical Population With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  12/31/1969
VA Healthcare System
mi
from
West Haven, CT
Open Label Ketamine Treatment for Major Depressive Disorder in Veterans
An Open Label Study of the Effects of Ketamine on a Veteran Clinical Population With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/31/1969
VA Healthcare System
mi
from
West Haven, CT
Click here to add this to my saved trials
Ketamine Anesthesia for Improvement of Depression in ECT
Ketamine vs. Methohexital Anesthesia for Improvement of Major Depressive Disorder in Electroconvulsive Therapy
Status: Enrolling
Updated:  12/31/1969
VA Puget Sound Health Care System
mi
from
Seattle, WA
Ketamine Anesthesia for Improvement of Depression in ECT
Ketamine vs. Methohexital Anesthesia for Improvement of Major Depressive Disorder in Electroconvulsive Therapy
Status: Enrolling
Updated: 12/31/1969
VA Puget Sound Health Care System
mi
from
Seattle, WA
Click here to add this to my saved trials
Feasibility of a Technology-Based Treatment Support System
Feasibility of a Technology-Based Treatment Support System
Status: Enrolling
Updated:  12/31/1969
Amita Health
mi
from
Arlington Heights, IL
Feasibility of a Technology-Based Treatment Support System
Feasibility of a Technology-Based Treatment Support System
Status: Enrolling
Updated: 12/31/1969
Amita Health
mi
from
Arlington Heights, IL
Click here to add this to my saved trials
Feasibility of a Behavioral Activation Trial
Feasibility of a Behavioral Activation Trial in Community Mental Health
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Feasibility of a Behavioral Activation Trial
Feasibility of a Behavioral Activation Trial in Community Mental Health
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
TMS for Adults With Autism and Depression
Transcranial Magnetic Stimulation for Adults With Autism Spectrum Disorder and Depression
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
TMS for Adults With Autism and Depression
Transcranial Magnetic Stimulation for Adults With Autism Spectrum Disorder and Depression
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Medibio DDA Confirmatory Performance Study
Medibio Depression Diagnostic Aid Confirmatory Performance Study
Status: Enrolling
Updated:  12/31/1969
CNS Network
mi
from
Garden Grove, CA
Medibio DDA Confirmatory Performance Study
Medibio Depression Diagnostic Aid Confirmatory Performance Study
Status: Enrolling
Updated: 12/31/1969
CNS Network
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Medibio DDA Confirmatory Performance Study
Medibio Depression Diagnostic Aid Confirmatory Performance Study
Status: Enrolling
Updated:  12/31/1969
CNS Network
mi
from
Torrance, CA
Medibio DDA Confirmatory Performance Study
Medibio Depression Diagnostic Aid Confirmatory Performance Study
Status: Enrolling
Updated: 12/31/1969
CNS Network
mi
from
Torrance, CA
Click here to add this to my saved trials
Medibio DDA Confirmatory Performance Study
Medibio Depression Diagnostic Aid Confirmatory Performance Study
Status: Enrolling
Updated:  12/31/1969
Lindner Center of HOPE
mi
from
Mason, OH
Medibio DDA Confirmatory Performance Study
Medibio Depression Diagnostic Aid Confirmatory Performance Study
Status: Enrolling
Updated: 12/31/1969
Lindner Center of HOPE
mi
from
Mason, OH
Click here to add this to my saved trials
Medibio DDA Confirmatory Performance Study
Medibio Depression Diagnostic Aid Confirmatory Performance Study
Status: Enrolling
Updated:  12/31/1969
OCCI, Inc.
mi
from
Salem, OR
Medibio DDA Confirmatory Performance Study
Medibio Depression Diagnostic Aid Confirmatory Performance Study
Status: Enrolling
Updated: 12/31/1969
OCCI, Inc.
mi
from
Salem, OR
Click here to add this to my saved trials
Medibio DDA Confirmatory Performance Study
Medibio Depression Diagnostic Aid Confirmatory Performance Study
Status: Enrolling
Updated:  12/31/1969
FutureSearch Trials
mi
from
Dallas, TX
Medibio DDA Confirmatory Performance Study
Medibio Depression Diagnostic Aid Confirmatory Performance Study
Status: Enrolling
Updated: 12/31/1969
FutureSearch Trials
mi
from
Dallas, TX
Click here to add this to my saved trials
Medibio DDA Confirmatory Performance Study
Medibio Depression Diagnostic Aid Confirmatory Performance Study
Status: Enrolling
Updated:  12/31/1969
White River Junction Veterans Affairs Medical Center
mi
from
White River Junction, VT
Medibio DDA Confirmatory Performance Study
Medibio Depression Diagnostic Aid Confirmatory Performance Study
Status: Enrolling
Updated: 12/31/1969
White River Junction Veterans Affairs Medical Center
mi
from
White River Junction, VT
Click here to add this to my saved trials
Medibio DDA Confirmatory Performance Study
Medibio Depression Diagnostic Aid Confirmatory Performance Study
Status: Enrolling
Updated:  12/31/1969
Epworth Clinic
mi
from
Camberwell,
Medibio DDA Confirmatory Performance Study
Medibio Depression Diagnostic Aid Confirmatory Performance Study
Status: Enrolling
Updated: 12/31/1969
Epworth Clinic
mi
from
Camberwell,
Click here to add this to my saved trials
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-911 in Healthy Subjects
A Single-center, Double-blind, Placebo-controlled, Randomized, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SUVN-911 After Single Ascending Doses and Multiple Ascending Doses in Healthy Male Subjects
Status: Enrolling
Updated:  12/31/1969
QuintilesIMS Phase 1 Services, LLC
mi
from
Kansas City, KA
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-911 in Healthy Subjects
A Single-center, Double-blind, Placebo-controlled, Randomized, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SUVN-911 After Single Ascending Doses and Multiple Ascending Doses in Healthy Male Subjects
Status: Enrolling
Updated: 12/31/1969
QuintilesIMS Phase 1 Services, LLC
mi
from
Kansas City, KA
Click here to add this to my saved trials
Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-911 in Healthy Subjects
A Phase I, Single-Center, Single Dose Study to Evaluate the Effect of Food, Gender, and Age on Safety and Pharmacokinetic Profiles of SUVN-911 Tablets Orally Administered in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
IQVIA Phase One Services, LLC
mi
from
Kansas City, KA
Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-911 in Healthy Subjects
A Phase I, Single-Center, Single Dose Study to Evaluate the Effect of Food, Gender, and Age on Safety and Pharmacokinetic Profiles of SUVN-911 Tablets Orally Administered in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
IQVIA Phase One Services, LLC
mi
from
Kansas City, KA
Click here to add this to my saved trials
Patient Management of Depression Through Technology: a Study of Digitally Enabled Engagement
Patient Management of Depression Through Technology: a Study of Digitally Enabled Engagement
Status: Enrolling
Updated:  12/31/1969
Advocate Christ Medical Center
mi
from
Oak Lawn, IL
Patient Management of Depression Through Technology: a Study of Digitally Enabled Engagement
Patient Management of Depression Through Technology: a Study of Digitally Enabled Engagement
Status: Enrolling
Updated: 12/31/1969
Advocate Christ Medical Center
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Assessing Symptomatic Clinical Episodes in Depression
A Randomized, Double-Blind, Active-Controlled Trial of AXS-05 Administered Orally to Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Axsome Study Site
mi
from
Beverly Hills, CA
Assessing Symptomatic Clinical Episodes in Depression
A Randomized, Double-Blind, Active-Controlled Trial of AXS-05 Administered Orally to Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Axsome Study Site
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Assessing Symptomatic Clinical Episodes in Depression
A Randomized, Double-Blind, Active-Controlled Trial of AXS-05 Administered Orally to Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Axsome Study Site
mi
from
Orlando, FL
Assessing Symptomatic Clinical Episodes in Depression
A Randomized, Double-Blind, Active-Controlled Trial of AXS-05 Administered Orally to Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Axsome Study Site
mi
from
Orlando, FL
Click here to add this to my saved trials
Assessing Symptomatic Clinical Episodes in Depression
A Randomized, Double-Blind, Active-Controlled Trial of AXS-05 Administered Orally to Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Axsome study site
mi
from
Bellevue, WA
Assessing Symptomatic Clinical Episodes in Depression
A Randomized, Double-Blind, Active-Controlled Trial of AXS-05 Administered Orally to Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Axsome study site
mi
from
Bellevue, WA
Click here to add this to my saved trials
Assessing Symptomatic Clinical Episodes in Depression
A Randomized, Double-Blind, Active-Controlled Trial of AXS-05 Administered Orally to Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Axsome Study Site
mi
from
Jacksonville, FL
Assessing Symptomatic Clinical Episodes in Depression
A Randomized, Double-Blind, Active-Controlled Trial of AXS-05 Administered Orally to Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Axsome Study Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
mi
from
Phoenix, AZ
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 033
mi
from
Scottsdale, AZ
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 033
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
mi
from
Arcadia, CA
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
mi
from
Arcadia, CA
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site #017
mi
from
Encino, CA
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site #017
mi
from
Encino, CA
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site #021
mi
from
Garden Grove, CA
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site #021
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 010
mi
from
Irvine, CA
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 010
mi
from
Irvine, CA
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 013
mi
from
Los Alamitos, CA
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 013
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 019
mi
from
National City, CA
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 019
mi
from
National City, CA
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
mi
from
Oceanside, CA
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
mi
from
Oceanside, CA
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
mi
from
Denver, CO
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
mi
from
Denver, CO
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 026
mi
from
Norwich, CT
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 026
mi
from
Norwich, CT
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 008
mi
from
Washington,
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 008
mi
from
Washington,
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 1543
mi
from
Jacksonville, FL
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 1543
mi
from
Jacksonville, FL
Click here to add this to my saved trials